GP KFPs / SAQs · musculoskeletal-presentations
Gout — KFP-style written assessment
KFP-style staged scenarios on gout in general practice: confirming the diagnosis, treating the acute flare with the right agent and dose, deciding who needs urate-lowering therapy and how to titrate it to target, prophylaxis during ULT initiation, febuxostat cardiovascular caution and lifestyle modification with honest effect sizes.
On this page
Study tools
Target exams
RACGP KFPRACGP AKTMRCGP AKT
Prompt
Gout: confirm it with crystals, treat the flare hard, then treat-to-target — diagnosis, acute therapy, ULT titration and prophylaxis
KFP 1 (10 marks)
A 52-year-old overweight publican wakes at 2 am with severe pain in his right first MTP joint. By mid-morning he cannot bear a sock on it. He drinks four beers most evenings. A locum last year told him 'it's just arthritis'. Serum urate today is 0.47 mmol/L; renal function normal. [20] [3]
- What is the clinical diagnosis and what would definitively confirm it? (3) [20]
- Outline first-line acute management with exact regimens, choosing sensibly for his occupation and preferences. (5) [1] [3] [16]
- How should his alcohol intake feature in the consultation now? (2) [12]
Model answers
- Acute gout (podagra): rapid-onset exquisitely tender first MTP synovitis in a middle-aged man with hyperuricaemia. Definitive confirmation is polarised-light microscopy of synovial fluid showing needle-shaped negatively birefringent MSU crystals; the 2015 ACR/EULAR criteria (92% sensitivity/89% specificity) formalise clinical diagnosis when aspiration is not feasible. [20]
- Treat early with one of the strongly recommended classes: low-dose colchicine (1 mg then 500 µg one hour later, then 500 µg daily–twice daily) — CLEAR showed efficacy equal to high-dose with placebo-like safety; an NSAID plus PPI (e.g., naproxen or indomethacin until 24h after resolution); or oral prednisolone 30-40 mg for 4-5 days (equivalent analgesia to indomethacin, fewer early adverse events). Intra-articular steroid is ideal if he prefers avoiding systemic tablets. NSAIDs carry GI risk in a drinker — weigh carefully. [1] [3] [16] [5]
- Address beer specifically: UK Biobank data show beer/cider carries the strongest beverage-gout association (HR 1.60 per pint/day in men). Frame reduction as part of flare prevention alongside weight loss, but be clear diet alone will not replace urate-lowering therapy if he meets its indications. [12] [19]
References14ShowHide
- [1]FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Rheumatol, 2020.PMID 32390306
- [3]Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum, 2010.PMID 20131255
- [4]White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, et al. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. N Engl J Med, 2018.PMID 29527974
- [5]Rainer TH, Cheng CH, Janssens HJ, Man CY, Tam LS, et al. Oral Prednisolone in the Treatment of Acute Gout: A Pragmatic, Multicenter, Double-Blind, Randomized Trial. Ann Intern Med, 2016.PMID 26903390
- [6]Wortmann RL, Macdonald PA, Hunt B, Jackson RL Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials. Clin Ther, 2010.PMID 21353107
- [7]Jennings CG, Mackenzie IS, Flynn R, Ford I, Nuki G, et al. Up-titration of allopurinol in patients with gout. Semin Arthritis Rheum, 2014.PMID 24560169
- [10]Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med, 2004.PMID 15014182
- [11]Choi HK, Curhan G Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ, 2008.PMID 18244959
- [12]Lyu JQ, Miao MY, Wang JM, Qian YW, Han WW, et al. Consumption of Total and Specific Alcoholic Beverages and Long-Term Risk of Gout Among Men and Women. JAMA Netw Open, 2024.PMID 39196557
- [13]GBD 2021 Gout Collaborators Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol, 2024.PMID 38996590
- [16]van Durme CM, Wechalekar MD, Landewé RB, Pardo Pardo J, Cyril S, et al. Non-steroidal anti-inflammatory drugs for acute gout. Cochrane Database Syst Rev, 2021.PMID 34882311
- [18]Park DJ, Kang JH, Lee JW, Lee KE, Wen L, et al. Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea. Arthritis Care Res (Hoboken), 2015.PMID 25047754
- [19]Afinogenova Y, Danve A, Neogi T Update on gout management: what is old and what is new. Curr Opin Rheumatol, 2022.PMID 34907116
- [20]Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis, 2015.PMID 26359487